• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

CardiAQ Valve Technologies

Neovasc settles final spat with Edwards unit CardiAQ Valve

April 18, 2019 By Fink Densford

Neovasc (NSDQ:NVCN) said late yesterday that it resolved the last remaining patent litigation between it and Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve Technologies by adding members of CardiAQ as co-inventors of the patents in dispute. Vancouver-based Neovasc said that it added CardiAQ’s Jeremy Brent Ratz and Arshad Quadri as co-inventors of three patents, each of which was related […]

Filed Under: Featured, Legal News, Replacement Heart Valves, Wall Street Beat Tagged With: CardiAQ Valve Technologies, Edwards Lifesciences, neovasc

Neovasc claims win in German TMVR patent case against Edwards unit CardiAQ Valve

March 21, 2019 By Brad Perriello

Neovasc (NSDQ:NVCN) today claimed a win in its patent infringement war with Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve Technologies, saying a German appeals court dismissed a case there. In June 2017 the District Court in Munich ruled that CardiAQ Valve contributed to the creation of Neovasc’s Tiara transcatheter mitral valve replacement, awarding”co-entitlement” rights to the patent in […]

Filed Under: Featured, Legal News, Replacement Heart Valves, Wall Street Beat Tagged With: CardiAQ Valve Technologies, Edwards Lifesciences, neovasc

Neovasc raises $65m to cover damages in CardiAQ case

November 17, 2017 By Fink Densford

Neovasc (NSDQ:NVCN) said today it closed an offering of approximately $37.5 million and a private placement of approximately $27.8 million to cover the roughly $42 million balance of damages and interest in a litigation with Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve. In its offering, Neovasc offered approximately 6.6 million Series A units and 19.1 million Series B units at a […]

Filed Under: Business/Financial News Tagged With: CardiAQ Valve Technologies, Edwards Lifesciences, neovasc

Neovasc surges on news of appeal, FDA nod for clinical trial

November 6, 2017 By Brad Perriello

Neovasc (NSDQ:NVCN) shares surged today in pre-market trading after the replacement heart valve maker said it’s exhausted the appeals process in its trade secret spat with Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve and that it won an FDA nod for a clinical trial. A jury in May 2016 awarded $70 million to CardiAQ after finding that Neovasc misappropriated trade secrets in developing […]

Filed Under: Clinical Trials, Legal News, Replacement Heart Valves Tagged With: CardiAQ Valve Technologies, Edwards Lifesciences, neovasc

Neovasc loses German patent case against Edwards Lifesciences unit CardiAQ Valve

June 16, 2017 By Brad Perriello

Neovasc (NSDQ:NVCN) shares are down more than 6% today after the replacement heart valve maker said it lost a patent case in Germany against arch-rival and Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve The District Court in Munich ruled that CardiAQ Valve contributed to the creation of Neovasc’s Tiara transcatheter mitral valve replacement, awarding”co-entitlement” rights to the patent in […]

Filed Under: Legal News, Patent Infringement, Replacement Heart Valves, Wall Street Beat Tagged With: CardiAQ Valve Technologies, Edwards Lifesciences, neovasc

Judge dings Neovasc for another $21m in spat with Edwards Lifesciences unit CardiAQ Valve

January 19, 2017 By Brad Perriello

A federal judge in Boston yesterday added another $21 million to the judgment against Neovasc (NSDQ:NVCN) in a trade secret spat with Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve that’s already cost Neovasc some $91 million. A jury in May awarded $70 million to CardiAQ after finding that Neovasc misappropriated trade secrets in developing its Tiara transcatheter mitral valve replacement […]

Filed Under: Legal News, Replacement Heart Valves, Wall Street Beat Tagged With: CardiAQ Valve Technologies, Edwards Lifesciences, neovasc

Neovasc granted stay as it appeals $70m CardiAQ loss

December 27, 2016 By Fink Densford

Neovasc (NSDQ:NVCN) said today it won a stay of judgement as it looks to appeal a $70 million loss to mitral valve rival and Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve. The stay from the US District Court for the District of Massachusetts restricts CardiAQ from enforcing the money judgement “pending the outcome of the appeal,” the company said. “‎Having […]

Filed Under: Legal News Tagged With: CardiAQ Valve Technologies, Edwards Lifesciences, neovasc

Neovasc dodges investor lawsuit over $70m loss to CardiAQ Valve

November 23, 2016 By Brad Perriello

Neovasc (NSDQ:NVCN) yesterday dodged an investor lawsuit brought in the wake of its $70 million loss to replacement mitral valve rival and Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve. A Massachusetts federal jury in May awarded $70 million to CardiAQ after finding that Neovasc misappropriated trade secrets in developing its Tiara transcatheter mitral valve replacement device. Edwards inherited the lawsuit […]

Filed Under: Legal News, Patent Infringement, Replacement Heart Valves Tagged With: CardiAQ Valve Technologies, Edwards Lifesciences, neovasc

Edwards Lifesciences subsidiary CardiAQ Valve wins another $21m in Neovasc patent spat

November 1, 2016 By Brad Perriello

A federal judge in Massachusetts yesterday added $21 million to the $70 million Neovasc (NSDQ:NVCN) owes Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve in their spat over replacement heart valve technology. A jury in May awarded $70 million to CardiAQ after finding that Neovasc misappropriated trade secrets in developing its Tiara transcatheter mitral valve replacement device. Edwards inherited the lawsuit when it acquired […]

Filed Under: Legal News, Patent Infringement, Replacement Heart Valves Tagged With: CardiAQ Valve Technologies, Edwards Lifesciences, neovasc

UPDATE: Neovasc fights Edwards Lifesciences’ bid to add to $70m trade theft loss

September 6, 2016 By Brad Perriello

UPDATED Sept. 9, 2016, with details on Neovasc’s response. Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve Technologies wants a federal judge in Massachusetts to add 33%, or more than $23 million, to the $70 million trade theft verdict lodged against Neovasc (NSDQ:NVCN) earlier this year. A federal jury in Massachusetts found in May that Neovasc stole trade secrets and breached a non-disclosure agreement with CardiAQ […]

Filed Under: Legal News, Patent Infringement, Replacement Heart Valves Tagged With: CardiAQ Valve Technologies, Edwards Lifesciences, neovasc

Neovasc wins round in patent battle with Edwards Lifesciences subsidiary CardiAQ Valve

May 31, 2016 By Brad Perriello

Neovasc (NSDQ:NVCN) last week won a round in its patent battle with Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve Technologies that’s already got it on the hook for some $70 million in damages. A federal jury in Massachusetts found earlier this month that Neovasc stole trade secrets and breached a non-disclosure agreement with CardiAQ in developing the Tiara transcatheter mitral valve replacement. Edwards inherited the lawsuit […]

Filed Under: Legal News, Patent Infringement, Replacement Heart Valves Tagged With: CardiAQ Valve Technologies, Edwards Lifesciences, neovasc

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS